Efficacy of intravesical Bacillus Calmette-Guérin therapy against tumor immune escape in an orthotopic model of bladder cancer

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 162-166

Spandidos Publications

Access to resources Recommend Favorite

Failure of Intravesical Interferon-Alfa-2b for the Treatment of Patients with Superficial Bladder Cancer Previously Failing Intravesical BCG Therapy

By Hudson M.A.   Ratliff T.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 115-118

Elsevier

Access to resources Recommend Favorite

Intravesical Administration of Radiolabelled Tumour-associated Monoclonal Antibody in Bladder Cancer

By Syrigos Konstantinos N.   Khawaja Magsood   Krausz Thomas   Williams Gordon   Epenetos Agamemnon A.  

Acta Oncologica, Vol. 38, Iss. 3, 1999-05 ,pp. : 379-382

Informa Healthcare

Access to resources Recommend Favorite

Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model

By Yuasa Takeshi   Sato Kiyoshi   Ashihara Eishi   Takeuchi Miki   Maita Shinya   Tsuchiya Norihiko   Habuchi Tomonori   Maekawa Taira   Kimura Shinya  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 493-502

Springer Publishing Company

Access to resources Recommend Favorite

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

By Yamashita M.   Rosser C.J.   Zhou J.H.   Zhang X.Q.   Connor R.J.   Engler H.   Maneval D.C.   Karashima T.   Czerniak B.A.   Dinney C.P.   Benedict W.F.   Hsieh J.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 313-314

Elsevier

Access to resources Recommend Favorite